DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-picoline ligand in cell-free media. Relations to their activity in cancer cell lines

被引:114
作者
Kasparkova, J [1 ]
Marini, V
Najajreh, Y
Gibson, D
Brabec, V
机构
[1] Acad Sci Czech Republ, Inst Biophys, CZ-61265 Brno, Czech Republic
[2] Hebrew Univ Jerusalem, Sch Pharm, Dept Med Chem & Nat Prod, IL-91120 Jerusalem, Israel
关键词
D O I
10.1021/bi0342315
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The global modification of mammalian and plasmid DNAs by novel platinum compounds, cis- or trans-[PtCl2(NH3)(Am)], where Am = NH3, nonplanar heterocycle piperidine, piperazine, or aromatic planar heterocycle 4-picoline, was investigated in cell-free media using various biochemical and biophysical methods. These modifications have been compared with the activity of these new compounds in several tumor cell lines including those resistant to antitumor cis-diamminedichloroplatinum(II) (cisplatin). The results show that the replacement of the NH3 group in cisplatin by the heterocyclic ligands does not considerably affect the DNA binding mode of this drug. Cytotoxicity studies have revealed that the replacement lowers the activity of the platinum compound in both sensitive and resistant cell lines. It has been suggested that the reduced activity of these analogues of cisplatin is associated with some features of the damaged DNA and/or its cellular processing. Alternatively, the reduced activity of the analogues of cisplatin might also be due to the factors that do not operate directly at the level of the target DNA, such as intracellular platinum uptake. In contrast to the analogues of cisplatin, the replacement of one ammine group by the heterocyclic ligand in its clinically ineffective trans isomer (transplatin) results in a radical enhancement of its activity in tumor cell lines. Importantly, this replacement also markedly alters the DNA binding mode of transplatin. The results support the view that one strategy of how to activate the trans geometry in bifunctional platinum(II) compounds including circumvention of resistance to cisplatin may consist of a chemical modification of the ineffective transplatin that results in an increased stability of its intrastrand cross-links in double-helical DNA and/or in an increased efficiency to form interstrand cross-links.
引用
收藏
页码:6321 / 6332
页数:12
相关论文
共 49 条
[1]  
ALLEY MC, 1988, CANCER RES, V48, P589
[2]   PT-195 NMR KINETIC AND MECHANISTIC STUDIES OF CIS-DIAMMINEDICHLOROPLATINUM AND TRANS-DIAMMINEDICHLOROPLATINUM(II) BINDING TO DNA [J].
BANCROFT, DP ;
LEPRE, CA ;
LIPPARD, SJ .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1990, 112 (19) :6860-6871
[3]   INTRASTRAND CROSS-LINKS ARE NOT FORMED IN THE REACTION BETWEEN TRANSPLATIN AND NATIVE DNA - RELATION WITH THE CLINICAL INEFFICIENCY OF TRANSPLATIN [J].
BOUDVILLAIN, M ;
DALBIES, R ;
AUSSOURD, C ;
LENG, M .
NUCLEIC ACIDS RESEARCH, 1995, 23 (13) :2381-2388
[4]   BIOPHYSICAL STUDIES OF THE MODIFICATION OF DNA BY ANTITUMOR PLATINUM COORDINATION-COMPLEXES [J].
BRABEC, V ;
KLEINWACHTER, V ;
BUTOUR, JL ;
JOHNSON, NP .
BIOPHYSICAL CHEMISTRY, 1990, 35 (2-3) :129-141
[5]   DNA INTERSTRAND CROSS-LINKS OF TRANS-DIAMMINEDICHLOROPLATINUM(II) ARE PREFERENTIALLY FORMED BETWEEN GUANINE AND COMPLEMENTARY CYTOSINE RESIDUES [J].
BRABEC, V ;
LENG, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (11) :5345-5349
[6]   DNA CONFORMATIONAL CHANGE PRODUCED BY THE SITE-SPECIFIC INTERSTRAND CROSS-LINK OF TRANS-DIAMMINEDICHLOROPLATINUM(II) [J].
BRABEC, V ;
SIP, M ;
LENG, M .
BIOCHEMISTRY, 1993, 32 (43) :11676-11681
[7]   Molecular aspects of resistance to antitumor platinum drugs [J].
Brabec, V ;
Kasparkova, J .
DRUG RESISTANCE UPDATES, 2002, 5 (3-4) :147-161
[8]   INFLUENCE OF SALTS AND PH ON POLAROGRAPHIC CURRENTS PRODUCED BY DENATURED DNA [J].
BRABEC, V ;
PALECEK, E .
BIOPHYSIK, 1970, 6 (04) :290-+
[9]   INTERACTION OF NUCLEIC-ACIDS WITH ELECTRICALLY CHARGED SURFACES .2. CONFORMATIONAL-CHANGES IN DOUBLE-HELICAL POLYNUCLEOTIDES [J].
BRABEC, V ;
PALECEK, E .
BIOPHYSICAL CHEMISTRY, 1976, 4 (01) :79-92
[10]   Steric control of DNA interstrand cross-link sites of trans platinum complexes:: specificity can be dictated by planar nonleaving groups [J].
Brabec, V ;
Neplechova, K ;
Kasparkova, J ;
Farrell, N .
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY, 2000, 5 (03) :364-368